Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMontanaro Uk Regulatory News (MTU)

Share Price Information for Montanaro Uk (MTU)

Share Price is delayed by 15 minutes
Get Live Data
109.00    0.50 (0.46%)
Bid:
108.00
Ask:
109.00
Spread: 1.00 (0.926%)
Market Cap: £121.84m
MTU Live PriceLast checked at - London Stock Exchange

Intraday Montanaro Uk Share Chart

Update from QuotedData

29 Apr 2025 09:49

RNS Number : 6156G
Montanaro UK Smlr Cos Inv Tst PLC
29 April 2025
 

Montanaro UK Smaller Companies - Update from QuotedData

29th April 2025

High growth, bigger yield

Montanaro UK Smaller Companies (MTU) has adopted a new enhanced dividend policy, paying out 1.5% of net asset value (NAV) every quarter. This will make it one of the highest-yielding UK equity strategies on the market. For traditional equity income investors, whose portfolios tend to be tilted towards more value-focused cash-generative stocks, MTU's combination of a high dividend yield and a strong focus on quality growth stocks differentiates it from peers.

UK equities were cheap relative to their history and to developed market peers prior to the tariff-related sell off; now they are even cheaper. In addition, the quality-growth small-cap stocks in which MTU invests have been out of vogue recently, with the market favouring large-cap value stocks instead.

As MTU's manager Charles Montanaro points out, the historic valuation gap provides investors with an attractive entry point. History has shown that buying stocks on these sorts of valuations can produce attractive long-term returns, and the magnitude of the discount of the UK's equity market relative to other developed global equity markets could in itself be a catalyst for the UK market to rerate.

Full Research:

https://quoteddata.com/research/montanaro-uk-smaller-companies-high-growth-bigger-yield-qd/

This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

NB: Marten & Co was paid to produce this note Montanaro UK Smaller Companies Investment Trust Plc, and it is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the Financial Conduct Authority. Marten & Co is not permitted to provide investment advice to individual investors categorised as Retail Clients under the rules of the Financial Conduct Authority.

QUOTEDDATA50 Gresham Street | London EC2V 7AYTel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAPKCBQFBKKOQB
Date   Source Headline
5th Jun 202612:26 pmRNSNet Asset Value(s)
4th Jun 20265:11 pmRNSTransaction in Own Shares
4th Jun 202612:28 pmRNSNet Asset Value(s)
3rd Jun 20265:13 pmRNSTransaction in Own Shares
3rd Jun 202611:59 amRNSNet Asset Value(s)
2nd Jun 20265:23 pmRNSTransaction in Own Shares
2nd Jun 202612:42 pmRNSNet Asset Value(s)
1st Jun 20265:16 pmRNSTransaction in Own Shares
1st Jun 202612:39 pmRNSNet Asset Value(s)
1st Jun 202610:15 amRNSTotal Voting Rights
29th May 20265:22 pmRNSTransaction in Own Shares
29th May 20261:26 pmRNSNet Asset Value(s)
28th May 20265:10 pmRNSTransaction in Own Shares
28th May 202612:25 pmRNSNet Asset Value(s)
27th May 20265:13 pmRNSTransaction in Own Shares
27th May 202612:37 pmRNSNet Asset Value(s)
26th May 20265:09 pmRNSTransaction in Own Shares
26th May 20261:49 pmRNSNet Asset Value(s)
22nd May 20265:14 pmRNSTransaction in Own Shares
22nd May 202611:29 amRNSNet Asset Value(s)
21st May 20265:17 pmRNSTransaction in Own Shares
21st May 202611:22 amRNSNet Asset Value(s)
20th May 20265:12 pmRNSTransaction in Own Shares
20th May 202612:42 pmRNSNet Asset Value(s)
20th May 202612:12 pmRNSResults of General Meeting
19th May 20265:14 pmRNSTransaction in Own Shares
19th May 202612:33 pmRNSNet Asset Value(s)
18th May 20265:27 pmRNSTransaction in Own Shares
18th May 202612:40 pmRNSNet Asset Value(s)
15th May 20265:15 pmRNSTransaction in Own Shares
15th May 202612:17 pmRNSNet Asset Value(s)
14th May 202612:09 pmRNSNet Asset Value(s)
13th May 20265:05 pmRNSTransaction in Own Shares
13th May 202612:37 pmRNSNet Asset Value(s)
12th May 20265:13 pmRNSTransaction in Own Shares
12th May 202612:55 pmRNSNet Asset Value(s)
11th May 20265:06 pmRNSTransaction in Own Shares
11th May 20261:19 pmRNSNet Asset Value(s)
8th May 20265:21 pmRNSTransaction in Own Shares
8th May 202612:27 pmRNSNet Asset Value(s)
7th May 20263:35 pmRNSHolding(s) in Company
7th May 202612:32 pmRNSNet Asset Value(s)
6th May 20265:10 pmRNSTransaction in Own Shares
6th May 20261:50 pmRNSNet Asset Value(s)
6th May 20268:57 amRNS-RAnnual Overview from QuotedData
5th May 20265:17 pmRNSTransaction in Own Shares
5th May 20261:52 pmRNSNet Asset Value(s)
1st May 20263:14 pmRNSPublication of Circular and Notice of Meeting
1st May 20262:21 pmRNSNet Asset Value(s)
1st May 202610:58 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.